{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:02:59Z","timestamp":1767146579346,"version":"build-2238731810"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3332021002"],"award-info":[{"award-number":["3332021002"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974011"],"award-info":[{"award-number":["81974011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021\u20131-I2M-019"],"award-info":[{"award-number":["2021\u20131-I2M-019"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.leukres.2022.106917","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:55:30Z","timestamp":1656982530000},"page":"106917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Ya-juan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-ni","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.leukres.2022.106917_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-021-00483-7","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021","volume":"11","author":"Hasib Sidiqi","year":"2021","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.leukres.2022.106917_bib2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.V97.6.1885","article-title":"Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy","volume":"97","author":"Choufani","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2022.106917_bib3","first-page":"289","article-title":"Clotting alterations in primary systemic amyloidosis","volume":"85","author":"Gamba","year":"2000","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2022.106917_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13506120902879269","article-title":"Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells","volume":"16","author":"Uchiba","year":"2009","journal-title":"Amyloid"},{"issue":"12","key":"10.1016\/j.leukres.2022.106917_bib5","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V77.12.2637.2637","article-title":"Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality","volume":"77","author":"Gastineau","year":"1991","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2022.106917_bib6","first-page":"85","article-title":"Characteristics of the aggregative function of thrombocytes in amyloidosis","volume":"60","author":"Charyev","year":"1988","journal-title":"Ter. Arkh"},{"issue":"2","key":"10.1016\/j.leukres.2022.106917_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mayocp.2020.06.061","article-title":"Coagulation abnormalities in light chain amyloidosis","volume":"96","author":"Abdallah","year":"2021","journal-title":"Mayo Clin. Proc."},{"issue":"14","key":"10.1016\/j.leukres.2022.106917_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM198104023041407","article-title":"Mechanism of factor X deficiency in systemic amyloidosis","volume":"304","author":"Furie","year":"1981","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.leukres.2022.106917_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-976169","article-title":"Hemostatic dysfunction in paraproteinemias and amyloidosis","volume":"33","author":"Zangari","year":"2007","journal-title":"Semin Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.leukres.2022.106917_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM197707142970203","article-title":"Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X","volume":"297","author":"Furie","year":"1977","journal-title":"N. Engl. J. Med"},{"issue":"18","key":"10.1016\/j.leukres.2022.106917_bib11","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2014-02-556514","article-title":"Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis","volume":"123","author":"Mahmood","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2022.106917_bib12","first-page":"513","volume":"6","author":"Tashiro","year":"2018","journal-title":"Direct Factor X sequestration Syst. amyloid Light-chain amyloidosis"},{"issue":"3","key":"10.1016\/j.leukres.2022.106917_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.0902-4441.2003.00200.x","article-title":"Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion","volume":"72","author":"Breems","year":"2004","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2022.106917_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2169\/internalmedicine.9263-17","article-title":"The long-term outcomes after VAD plus SCT therapy in a patient with AL amyloidosis and severe factor X deficiency","volume":"57","author":"Iwadate","year":"2018","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.leukres.2022.106917_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/13506129.2019.1663815","article-title":"Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency","volume":"26","author":"Wu","year":"2019","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.leukres.2022.106917_bib16","first-page":"99","article-title":"Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis","volume":"36","author":"Shen","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.leukres.2022.106917_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127180","article-title":"The successful diagnosis and typing of systemic amyloidosis using a microwave-assisted filter-aided fast sample preparation method and LC\/MS\/MS analysis","volume":"10","author":"Sun","year":"2015","journal-title":"Plos One"},{"issue":"11","key":"10.1016\/j.leukres.2022.106917_bib18","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/leu.2012.100","article-title":"Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis","volume":"26","author":"Comenzo","year":"2012","journal-title":"Leukemia"},{"issue":"36","key":"10.1016\/j.leukres.2022.106917_bib19","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2022.106917_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2017-02-767467","article-title":"Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome","volume":"130","author":"Milani","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106917_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.2830030303","article-title":"Coagulopathy in amyloidosis: combined deficiency of factors IX and X","volume":"3","author":"McPherson","year":"1977","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2022.106917_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-128-7-199804010-00031","article-title":"AL amyloidosis combined with acquired factor V deficiency","volume":"128","author":"Gatel","year":"1998","journal-title":"Ann. Intern Med"},{"issue":"1","key":"10.1016\/j.leukres.2022.106917_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.hemonc.2018.05.002","article-title":"Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease","volume":"12","author":"Patel","year":"2019","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"issue":"1","key":"10.1016\/j.leukres.2022.106917_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MBC.0000000000000367","article-title":"Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency","volume":"27","author":"Cordes","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.leukres.2022.106917_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis","volume":"110","author":"Mumford","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"19","key":"10.1016\/j.leukres.2022.106917_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM197911083011907","article-title":"Factor X deficiency in primary amyloidosis: resolution after splenectomy","volume":"301","author":"Greipp","year":"1979","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.leukres.2022.106917_bib27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1046\/j.1365-2141.2001.02667.x","article-title":"Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency","volume":"112","author":"Boggio","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106917_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<68::AID-AJH10>3.0.CO;2-6","article-title":"Normalization of plasma factor X levels in amyloidosis after plasma exchange","volume":"54","author":"Beardell","year":"1997","journal-title":"Am. J. Hematol."}],"updated-by":[{"DOI":"10.1016\/j.leukres.2022.107003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T15:41:05Z","timestamp":1711122065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"alternative-id":["S0145212622001436"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106917","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106917"}}